🦊/Investors

Cambridge Capital Group

Angel network

Cambridge · Pre-Seed–Growth · 2 people tracked

Find your way into Cambridge Capital Group

1,360 people in our graph share verified history with the Cambridge Capital Group team — schools, employers, funds. One of them is your warm intro.

Akshat Goenkaunlockedknows Philip Winter · together at University of Pennsylvania (overlapped)
×4knows the team · via Y Combinator
knows the team · via The London School of Economics and Political Science (LSE)
knows the team · via Creator Fund
×2knows the team · via University of Pennsylvania
knows the team · via University of Cambridge
Fox Verdict
Sign up to see your fit

Investment thesis

Cambridge Capital Group invests in early-stage technology opportunities — seed, start-up and early growth — based in the UK's Golden Triangle (Cambridge, Oxford, London). As an angel network it pools private investors, family offices and venture funds to fund high-tech startups, having committed over £50M across more than 100 companies in 25 years.

Source: firm website, verified Aug 3, 2026.

Stage
Pre-Seed–Growth
HQ
Cambridge, GB
Instruments
Equity
Founded
2000
Last 12 months
1 investment
Tracked investments
4

Team · 2 people

from curated

What they invest in

from 4 of 4 portfolio companies

Medical Devices ×3Biotech ×2Healthtech ×2SaaS ×2AI & Machine Learning ×1Data & Infrastructure ×1Deep Tech ×1Digital Health ×1

HQs:United Kingdom×3

Investments · 4 tracked

founders shown can be your intro path
iFASTifastdiagnostics.cominMay 2026✓ verified

iFAST Diagnostics develops rapid antimicrobial susceptibility testing (AST) technology that delivers susceptibility test results in under 3 hours, significantly faster than the standard 40-hour process.

BiotechHealthtechMedical DevicesWhiteley, GB

Toby King(CEO)in

Co-investorsMeridian Health VenturesInnovate UKRaw VenturesFuture Planet CapitalUK Innovation & Science Seed Fund

Semarion - companysemarion.comin𝕏✓ verified

Semarion is a University of Cambridge spin-out developing the SemaCyte platform, which converts adherent cells into barcoded, ready-to-use reagents for accelerated drug discovery and cell-based research.

BiotechDeep TechMedical DevicesNew MaterialsSaaSCambridge, GB

Jeroen Verheyen(CEO and Co-Founder)inTarun Vemulkar(Co-founder & CTO)in

Co-investorsThe FSE GroupFound CapitalStart CodonEMV CapitalMartlet CapitalParkwalk Advisors

Arachnysarachnys.comin

Solytics Partners provides risk management, financial crime and compliance (AML/CFT), data analytics, and ESG/climate risk services and technology to financial institutions such as banks, capital markets firms, and insurers.

AI & Machine LearningData & InfrastructureEnterprise SoftwareFintechSaaS

Co-investorsMartlet CapitalQED

PneumaCarepneumacare.comin𝕏

PneumaCare develops Structured Light Plethysmography (SLP) technology and markets Thora-3Di, a non-contact, non-invasive 3D-imaging device for lung function assessment used in paediatric, ICU, and thoracic surgery hospital settings.

Digital HealthHealthtechMedical DevicesCambridge, GB

Bart A. Lewin(Chief Executive Officer)in

Co-investorsCambridge Angels group

Portfolio news

latest coverage across their companies

Frequently asked questions

What stage does Cambridge Capital Group invest at?
Cambridge Capital Group invests at the Pre-Seed, Seed, Series A, Growth stages.
What sectors does Cambridge Capital Group focus on?
Cambridge Capital Group focuses on AI & Machine Learning, Biotech, Deep Tech, Enterprise Software, Fintech, Hardware, IoT, Medical Devices, SaaS.
Where is Cambridge Capital Group located?
Cambridge Capital Group is headquartered in Cambridge, GB.

Similar investors

Featured in lists